HIF-1α expression is associated with the pathological response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma patients and can be predicted using CECT features

HIF-1α表达与胰腺导管腺癌患者新辅助化疗的病理反应相关，并且可以通过增强CT（CECT）特征进行预测。